Search by Drug Name or NDC
NDC 23155-0843-05 METFORMIN HYDROCHLORIDE 1000 mg/1 Details
METFORMIN HYDROCHLORIDE 1000 mg/1
METFORMIN HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is METFORMIN HYDROCHLORIDE.
Product Information
| NDC | 23155-0843 |
|---|---|
| Product ID | 23155-843_f999653d-b79a-b048-e053-6394a90af869 |
| Associated GPIs | |
| GCN Sequence Number | 040974 |
| GCN Sequence Number Description | metformin HCl TABLET 1000 MG ORAL |
| HIC3 | C4L |
| HIC3 Description | ANTIHYPERGLYCEMIC, BIGUANIDE TYPE |
| GCN | 10857 |
| HICL Sequence Number | 004763 |
| HICL Sequence Number Description | METFORMIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | METFORMIN HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metformin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1000 |
| Active Ingredient Units | mg/1 |
| Substance Name | METFORMIN HYDROCHLORIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Biguanide [EPC], Biguanides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213320 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0843-05 (23155084305)
| NDC Package Code | 23155-843-05 |
|---|---|
| Billing NDC | 23155084305 |
| Package | 500 TABLET in 1 BOTTLE (23155-843-05) |
| Marketing Start Date | 2023-01-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.02348 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | METFORMIN HCL 1,000 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis